Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Receivables - Other (2017 - 2025)

Historic Receivables - Other for Summit Therapeutics (SMMT) over the last 6 years, with Q1 2025 value amounting to $12000.0.

  • Summit Therapeutics' Receivables - Other changed N/A to $12000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $12000.0, marking a year-over-year change of. This contributed to the annual value of $574000.0 for FY2021, which is N/A changed from last year.
  • Summit Therapeutics' Receivables - Other amounted to $12000.0 in Q1 2025.
  • In the past 5 years, Summit Therapeutics' Receivables - Other ranged from a high of $1.1 million in Q2 2022 and a low of $12000.0 during Q1 2025
  • For the 4-year period, Summit Therapeutics' Receivables - Other averaged around $397833.3, with its median value being $322500.0 (2022).